Unichrom Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
as on 14-12-2024
- Paid Up Capital ₹ 0.41 M
as on 14-12-2024
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.40 Cr
as on 14-12-2024
- Satisfied Charges ₹ 6.90 Cr
as on 14-12-2024
- Revenue -27.74%
(FY 2021)
- Profit -996.57%
(FY 2021)
- Ebitda -119.34%
(FY 2021)
- Net Worth -304.35%
(FY 2021)
- Total Assets -15.36%
(FY 2021)
About Unichrom Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.41 M.
The company currently has active open charges totaling ₹6.40 Cr. The company has closed loans amounting to ₹6.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Premjit Saini, Navjit Saini, and Amitsingh Saini serve as directors at the Company.
- CIN/LLPIN
U28920MH1986PTC039555
- Company No.
039555
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Apr 1986
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Unichrom Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Premjit Saini  | Director | 19-Dec-2011 | Current |
| Navjit Saini | Director | 19-Dec-2011 | Current |
| Amitsingh Saini | Director | 06-Jun-2023 | Current |
Financial Performance of Unichrom Laboratories.
Unichrom Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 27.74% decrease. The company also saw a substantial fall in profitability, with a 996.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 304.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unichrom Laboratories?
In 2021, Unichrom Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Apr 2024 | ₹1.50 Cr | Open |
Others Creation Date: 22 Dec 2023 | ₹4.00 M | Open |
Others Creation Date: 24 Jun 2023 | ₹4.25 Cr | Open |
How Many Employees Work at Unichrom Laboratories?
Unichrom Laboratories has a workforce of 33 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unichrom Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unichrom Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
